Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Working Capital Changes (2021 - 2025)

Historic Other Working Capital Changes for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $507000.0.

  • Kiniksa Pharmaceuticals International's Other Working Capital Changes fell 9274.89% to $507000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year increase of 10541.49%. This contributed to the annual value of $19.6 million for FY2024, which is 17663.79% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Other Working Capital Changes stood at $507000.0 for Q3 2025, which was down 9274.89% from $6.9 million recorded in Q2 2025.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Other Working Capital Changes peaked at $14.3 million during Q3 2022, and registered a low of -$14.3 million during Q4 2022.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Other Working Capital Changes had a median value of $1.8 million in 2024 and averaged $2.7 million.
  • The largest annual percentage gain for Kiniksa Pharmaceuticals International's Other Working Capital Changes in the last 5 years was 295035.63% (2022), contrasted with its biggest fall of 105149.07% (2022).
  • Kiniksa Pharmaceuticals International's Other Working Capital Changes (Quarter) stood at -$1.2 million in 2021, then tumbled by 1051.49% to -$14.3 million in 2022, then surged by 38.1% to -$8.8 million in 2023, then skyrocketed by 134.38% to $3.0 million in 2024, then plummeted by 83.33% to $507000.0 in 2025.
  • Its Other Working Capital Changes stands at $507000.0 for Q3 2025, versus $6.9 million for Q2 2025 and $5.3 million for Q1 2025.